Cardinal Health Extends Receivables Financing Facility to 2028 in Amended Agreement with Major Financial Institutions

Reuters
10/03
Cardinal Health Extends Receivables Financing Facility to 2028 in Amended Agreement with Major Financial Institutions

**Cardinal Health Extends Receivables Financing Facility to 2028** Cardinal Health Inc. has announced an amendment to its existing receivables purchase agreement, extending the term of its financing facility to September 28, 2028. The amendment, executed on September 30, 2025, involves several affiliated financing subsidiaries including Cardinal Health Funding, LLC and Cardinal Health 23 Funding, LLC, as well as major financial institutions such as Wells Fargo, Liberty Street Funding, The Bank of Nova Scotia, PNC Bank, Bank of America, Victory Receivables Corporation, and MUFG Bank. The facility, originally established in 2023, enables Cardinal Health to optimize its working capital by selling certain receivables to these financial partners. The extension underscores the continued support from Cardinal Health's banking partners, many of whom also participate in the company's $2 billion revolving credit facility and other financial programs. The full details of the amendment are available in Cardinal Health's latest 8-K filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardinal Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000721371-25-000122), on October 03, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10